Purchase Order HHSD2002017M94631P
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $10,530.15 Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a PERKINELMER BIOQULE NGS AUTOMATED LIBRARY PREP INSTRUMENT. The contract has a completion date of September 1, 2023 and was awarded on August 25, 2023. This award does not appear to have a set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services, and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $180,772.01 firm-fixed-price purchase order to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract, which does not have a set-aside designation, is for the purchase of a CHEMAGIC 360 device to support the agency's Coronavirus COVID-19 response efforts. Revvity Health Sciences, Inc. is a subsidiary of Revvity Inc., which has previously...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $249,015.99 firm-fixed-price purchase order contract to Revvity Health Sciences, Inc. for the PERKIN ELMORE-SCICLONE G3 NGSX medical imaging product. The contract will be performed in Shelton, Connecticut and has a completion date of October 15, 2022. Revvity Health Sciences, Inc. is a for-profit manufacturer of goods that provides a wide variety of medical devices and equipment, as well as...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $226,845.75 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of CHERMAGIC 360 AND JANUS G3 QPCR WORKSTATION. This equipment supports the CDC's COVID-19 pandemic response efforts. The contract was awarded on June 16, 2020, with a completion date of August 10, 2020. The place of performance is Shelton, CT. Revvity Health Sciences, Inc. is a for-profit manufacturer...
- This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. (a subsidiary of PerkinElmer, Inc.) for the provision of laboratory equipment. The contract has a ceiling value of $98,683.66 and a period of performance ending on July 3, 2017. The contract was not set aside for any specific business category. Revvity Health Sciences is a for-profit manufacturer that has received previous prime contract awards and...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for $78,680.00 to provide laboratory supplies. The contract has an ultimate completion date of August 30, 2015 and does not utilize a small business set-aside. Revvity Health Sciences is a manufacturer of medical imaging products and services that has delivered a variety of specialized...
- Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a one-year, firm fixed price purchase order valued at twenty-one thousand, five hundred seven dollars and eighty-four cents ($21,507.84) by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract calls for Perkin Elmer service delivery in support of CDC programs. Performance will take place in Shelton, Connecticut. The award draws from CDC funding to...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of a SCICLONE G3 NGSX HT WORKSTATION laboratory instrument. The contract has a potential value of $242,491.55 and a period of performance through September 30, 2020. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides a range of medical...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Revvity Health Sciences, Inc., a manufacturer of medical imaging products and services. The $87,410.15 firm-fixed-price purchase order is for the delivery of consumables. The contract has no set-aside designation and has an ultimate completion date of May 27, 2015. Revvity Health Sciences, Inc. does business as PerkinElmer Inc. and has previously received other prime...
- This is a prime contract award from the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. for the delivery of laboratory equipment. The contract has a firm fixed price of $182,544.00 and was awarded on July 17, 2018 with a completion date of September 30, 2018. The contract was not set aside for any specific business type. Revvity Health Sciences is a for-profit organization that manufactures medical imaging products...
The Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) awarded a firm fixed-price purchase order worth $137,053.70 to Revvity Health Sciences, Inc. for the PERKINELMER CHEMAGIC 360 INSTRUMENT. The contract, which had a completion date of July 30, 2021, was awarded on June 30, 2017. The place of performance was in Atlanta, Georgia. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and laboratory equipment that has provided similar devices and services to federal agencies such as the National Institutes of Health, Department of Defense, and Department of Veterans Affairs through prime contracts and subcontracts. This award did not utilize a small business set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 4 | Exercise an Option | $15.5k | 5/21/20 | |
| 3 | Change Order | $15.5k | 2/26/19 | |
| 2 | Exercise an Option | $15.5k | 7/30/18 | |
| 1 | Other Administrative Action | $0 | 8/1/17 | |
| Not listed | Not listed | $90.6k | 6/30/17 |